PMC:7463108 / 4172-4421 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":193,"end":201},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and Gross 2020; Samuels et al."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T25029","span":{"begin":141,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and Gross 2020; Samuels et al."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":110,"end":123},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_3216"}],"text":"By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and Gross 2020; Samuels et al."}

{"project":"LitCovid-PubTator","denotations":[{"id":"65","span":{"begin":110,"end":123},"obj":"Chemical"},{"id":"73","span":{"begin":193,"end":201},"obj":"Disease"}],"attributes":[{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D002047"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and Gross 2020; Samuels et al."}

{"project":"LitCovid-sentences","denotations":[{"id":"T36","span":{"begin":0,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and Gross 2020; Samuels et al."}

{"project":"2_test","denotations":[{"id":"32876803-31420089-62957825","span":{"begin":92,"end":96},"obj":"31420089"}],"text":"By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and Gross 2020; Samuels et al."}